PellePharm

PellePharm, Inc. operates in the biotechnology industry. The company was incorporated in 2012 and is based in Menlo Park, California. Focused on the development of topical patidegib, a first-in-class topical hedgehog inhibitor, to decrease the number of surgically-eligible basal cell carcinomas (BCCs) in persons with Gorlin Syndrome and those with sporadic BCCs.
Type
Private
HQ
Menlo Park, US
Founded
2012
Employees
5 (est)
PellePharm was founded in 2012 and is headquartered in Menlo Park, US

PellePharm Locations

Menlo Park, US

PellePharm Metrics

PellePharm Summary

Founding Date

2012

Total Funding

$11.4 M

Latest funding size

$3.25 M

Time since last funding

5 months
We estimate that PellePharm's latest funding round in August 2016 was $3.25 M. In total, PellePharm has raised $11.4 M

PellePharm Company Life

You may also be interested in